エネダイネの活性化における適合制御
M F Semmelhack1, Lingyun Wu, Robert A Pascal
1Department of Chemistry, Princeton University, Princeton, NJ 08544, USA. mfshack@princeton.edu
Journal of the American Chemical Society
|August 28, 2003
まとめ
計算による研究では,bicyclo[7.3.1]tridec-4-ene-2,6-diyneの椅子のコンフォマーがより反応的であることが予測されました. ブリッジデリバティブの合成がこれを確認し,エネディインの毒素のサイクルアロマト化が誘発されたことを示した.
科学分野:
- 有機化学 オーガニック・ケミストリー
- コンピューティング・ケミストリー
- 薬用化学 薬用化学について
背景:
- バイサイクロ[7.3.1]トリデック-4-エネ-2,6-ディインの枠組みは,強力なエネディイン毒素であるカリケアミシンの中心にある.
- このフレームワークの構造動態と反応性を理解することは,薬物設計と毒素メカニズムを理解するために不可欠です.
研究 の 目的:
- 自転車[7.3.1]tridec-4-ene-2,6-diyneのフレームワークの椅子とボートのコンフォーマーの相対的反応性を計算的に調査するために.
- 構成的にロックされた微分を合成し,研究することによって,計算予測を実験的に検証する.
主な方法:
- 密度関数理論 (DFT) の計算を用いて,電子構造をモデル化し,異なるコンフォーマーの反応性を予測した.
- 機能化されたbicyclo[7.3.1]tridec-4-ene-2,6-diyne誘導体の合成,2原子のブリッジでボートの形状を強制する.
- 形状鎖の解き放たれた時のサイクロアロマチゼーションの速度を決定するための運動学的研究.
主要な成果:
- DFTの計算によると,椅子のコンフォーマーは,ボートのコンフォーマよりもサイクロアロマチゼーションに対して有意に反応性があることが示された.
- ボートの形状に閉じ込められた合成派生体は,室温で安定していた.
- ブリッジの割れは,サイクロアロマチゼーションを開始し,23°Cで半減期42.5分で進行し,椅子の形状を通して提案されたメカニズムをサポートしました.
結論:
- 実験結果は,チェアコンフォーマーのより高い反応性に関する計算予測を確認した.
- この研究は,新治療薬の開発や天然製品のメカニズムを理解するための意味を持つ,形状制御によるエネディイン毒素の活性を誘発するための新しい戦略を導入しています.
関連する概念動画
Induced-fit Model
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...


